AI assistant
SynAct Pharma Major Shareholding Notification 2023
3114_iss_2023-11-06_33dcf20d-dcdf-469f-924e-16f44b7c88bb.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer
Issuer SynAct Pharma AB
Holder
Ryan Quinn
Instrument
| Instrument | Shares SE0008241491 | |
|---|---|---|
| Before the transaction | ||
| Shares | 3,432,394 | |
| Voting rights | 3,432,394 | |
| Transaction | ||
| Reason for major shareholding notification Sell | ||
| Date | 01/11/2023 | |
| Limit for number of shares | 5 % | |
| Limit for number of votes | 5 % | |
| After the transaction | ||
| Quantity | ||
| Shares | 1,500,000 | |
| Directly held voting rights | 0 | |
| Indirectly held voting rights | 1,500,000 | |
| Percentage | ||
| Directly held shares | 4.217 % | |
| Directly held voting rights | 0 % | |
| Indirectly held voting rights | 4.217 % |
Resulting distribution of total holdings
| Percentage of voting rights: |
Number of underlying shares: |
|
|---|---|---|
| Shares | 4.217 % | 1,500,000 |
| Instruments - FITA Ch. 4, section 2, first paragraph, line 2 Instruments - FITA Ch. 4, section 2, first paragraph, line 3 |
||
| - Physically settled - Cash settled |
||
| Total | 4.217 % | 1,500,000 |
| Group total holdings |
||
| Voting rights 1,500,000 Percentage of voting rights 4.217 |
||
| Published 06/11/2023 20:43 |
||
| Contact | ||
| Name Dan LaVine |
||
| Phone +1 (610) 7472359 Email [email protected] |
||
| CLOSE |
[email protected] Tfn 08-408 980 37 Fax 08-24 39 25